ABSTRACT
Cytochromes P450 play key roles in drug metabolism and disease by oxidizing a wide variety of natural and xenobiotic compounds. High-resolution crystal structures of P450cam bound to ruthenium sensitizer-linked substrates reveal an open conformation of the enzyme that allows substrates to access the active center via a 22-A deep channel. Interactions of alkyl and fluorinated biphenyl linkers with the channel demonstrate the importance of exploiting protein dynamics for specific inhibitor design. Large changes in peripheral enzyme structure (F and G helices) couple to conformational changes in active center residues (I helix) implicated in proton pumping and dioxygen activation. Common conformational states among P450cam and homologous enzymes indicate that static and dynamic variability in the F/G helix region allows the 54 human P450s to oxidize thousands of substrates.
Subject(s)
Camphor 5-Monooxygenase/chemistry , Ruthenium/metabolism , Binding Sites , Camphor 5-Monooxygenase/metabolism , Catalysis , Protein ConformationABSTRACT
To probe the structural basis for protein histidine kinase (PHK) catalytic activity and the prospects for PHK-specific inhibitor design, we report the crystal structures for the nucleotide binding domain of Thermotoga maritima CheA with ADP and three ATP analogs (ADPNP, ADPCP and TNP-ATP) bound with either Mg(2+) or Mn(2+). The conformation of ADPNP bound to CheA and related ATPases differs from that reported in the ADPNP complex of PHK EnvZ. Interactions of the active site with the nucleotide gamma-phosphate and its associated Mg(2+) ion are linked to conformational changes in an ATP-lid that could mediate recognition of the substrate domain. The inhibitor TNP-ATP binds CheA with its phosphates in a nonproductive conformation and its adenine and trinitrophenyl groups in two adjacent binding pockets. The trinitrophenyl interaction may be exploited for designing CheA-targeted drugs that would not interfere with host ATPases.
Subject(s)
Adenosine Diphosphate/metabolism , Adenosine Triphosphate/metabolism , Bacterial Proteins , Membrane Proteins/chemistry , Membrane Proteins/metabolism , Protein Kinases/chemistry , Protein Kinases/metabolism , Thermotoga maritima/enzymology , Adenosine Triphosphatases/antagonists & inhibitors , Adenosine Triphosphatases/chemistry , Adenosine Triphosphatases/metabolism , Adenosine Triphosphate/analogs & derivatives , Binding Sites , Cations, Divalent/metabolism , Chromatography, Gel , Crystallography, X-Ray , Histidine Kinase , Hydrogen Bonding , Magnesium/metabolism , Membrane Proteins/antagonists & inhibitors , Methyl-Accepting Chemotaxis Proteins , Models, Molecular , Phosphorylation , Protein Kinase Inhibitors , Protein Structure, Tertiary , SolventsABSTRACT
Histidine kinases allow bacteria, plants, and fungi to sense and respond to their environment. The 2.6 A resolution crystal structure of Thermotoga maritima CheA (290-671) histidine kinase reveals a dimer where the functions of dimerization, ATP binding, and regulation are segregated into domains. The kinase domain is unlike Ser/Thr/Tyr kinases but resembles two ATPases, Gyrase B and Hsp90. Structural analogies within this superfamily suggest that the P1 domain of CheA provides the nucleophilic histidine and activating glutamate for phosphotransfer. The regulatory domain, which binds the homologous receptor-coupling protein CheW, topologically resembles two SH3 domains and provides different protein recognition surfaces at each end. The dimerization domain forms a central four-helix bundle about which the kinase and regulatory domains pivot on conserved hinges to modulate transphosphorylation. Different subunit conformations suggest that relative domain motions link receptor response to kinase activity.
Subject(s)
Bacterial Proteins/chemistry , Membrane Proteins/chemistry , Protein Conformation , Protein Kinases/chemistry , Signal Transduction , Thermotoga maritima/enzymology , Adenosine Triphosphatases/chemistry , Amino Acid Sequence , Bacterial Proteins/metabolism , Dimerization , Histidine Kinase , Hydrolysis , Membrane Proteins/metabolism , Methyl-Accepting Chemotaxis Proteins , Molecular Sequence Data , Phosphorylation , Protein Kinases/metabolism , Sequence Homology, Amino AcidABSTRACT
The function and regulation of the receptorlike transmembrane protein tyrosine phosphatases (RPTPs) are not well understood. Ligand-induced dimerization inhibited the function of the epidermal growth factor receptor (EGFR)-RPTP CD45 chimera (EGFR-CD45) in T cell signal transduction. Properties of mutated EGFR-CD45 chimeras supported a general model for the regulation of RPTPs, derived from the crystal structure of the RPTPalpha membrane-proximal phosphatase domain. The phosphatase domain apparently forms a symmetrical dimer in which the catalytic site of one molecule is blocked by specific contacts with a wedge from the other.
Subject(s)
Leukocyte Common Antigens/metabolism , Protein Tyrosine Phosphatases/antagonists & inhibitors , T-Lymphocytes/metabolism , Binding Sites , Calcium/metabolism , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Dimerization , Epidermal Growth Factor/metabolism , Epidermal Growth Factor/pharmacology , ErbB Receptors/chemistry , ErbB Receptors/metabolism , Humans , Leukocyte Common Antigens/chemistry , Ligands , Lymphocyte Activation , Mutation , Phosphorylation , Protein Tyrosine Phosphatases/chemistry , Protein Tyrosine Phosphatases/metabolism , Protein-Tyrosine Kinases/metabolism , Receptors, Antigen, T-Cell/metabolism , Recombinant Fusion Proteins/antagonists & inhibitors , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Signal Transduction , T-Lymphocytes/immunology , Tumor Cells, Cultured , ZAP-70 Protein-Tyrosine KinaseABSTRACT
Receptor-like protein-tyrosine phosphatases (RPTPs), like their non-receptor counterparts, regulate the level of phosphotyrosine-containing proteins derived from the action of protein-tyrosine kinases. RPTPs are type-I integral membrane proteins which contain one or two catalytic domains in their cytoplasmic region. It is not known whether extracellular ligands regulate the activity of RPTPs. Here we describe the crystal structure of the membrane-proximal catalytic domain (D1) of a typical RPTP, murine RPTP alpha. Significant structural deviations from the PTP1B fold reside within the amino-terminal helix-turn-helix segment of RPTPalphaD1 (residues 214 to 242) and a distinctive two-stranded beta-sheet formed between residues 211-213 and 458-461. The turn of the N-terminal segment inserts into the active site of a dyad-related D1 monomer. On the basis of two independent crystal structures, sequence alignments, and the reported biological activity of EGF receptor/CD45 chimaeras, we propose that dimerization and active-site blockage is a physiologically important mechanism for downregulating the catalytic activity of RPTPalpha and other RPTPs.
